Table 1 Baseline characteristics of all included patients.

From: Implications for the diagnosis of aspiration and aspergillosis in critically ill patients with detection of galactomannan in broncho-alveolar lavage fluids

N = 69

ASP

(n = 39)

pIPA

(n = 30)

p

Demographics

 Age [Years] †

72 (61, 76)

61 (54, 69)

< 0.01

 Females

9 (23%)

9 (30%)

0.5

Underlying diseases

 COPD

7 (18%)

6 (20%)

0.8

 Coronary artery disease

10 (26%)

10 (26%)

0.12

 Diabetes mellitus

5 (13%)

7 (23%)

0.3

 Heart insufficiency

12 (31%)

15 (50%)

0.10

 Liver cirrhosis

2 (5.1%)

15 (50%)

< 0.001

 Alcohol abuse

5 (13%)

6 (20%)

0.5

 Chemotherapy

2 (5.1%)

3 (10%)

0.6

 Solid organ transplantation

0 (0%)

19 (63%)

< 0.001

  Liver

0 (0%)

13 (43%)

< 0.001

  Kidney

0 (0%)

6 (20%)

< 0.01

 Corticosteroid therapy

8 (21%)

29 (97%)

< 0.001

  Because of sepsis

7 (18%)

10 (33%)

0.14

 Bacteremia

10 (26%)

10 (33%)

0.5

 Dialysis

3 (7.7%)

12 (40%)

< 0.01

 Delirium

20 (59%)

14 (48%)

0.4

 Stroke

6 (15%)

3 (10%)

0.7

 ASA Status‡

  

0.04

  2

7 (18%)

0 (0%)

 

  3

22 (56%)

17 (57%)

 

  4

9 (23%)

12 (40%)

 

  5

1 (2.6%)

1 (3.3%)

 

SOFA ICU admission†

7 (3, 11)

11 (6, 16)

< 0.01

Time on ICU [d] †

28 (20, 45)

47 (28, 85)

0.02

Mechanical ventilation [h] †

249 (96, 589)

453 (187, 828)

0.07

Death at 28 days

12 (32%)

9 (31%)

0.9

  1. Data are presented as n (%).
  2. †Values are presented as median, (Interquartile range).
  3. ‡Values are presented as mean ± standard deviation.
  4. COPD (Chronic obstructive pulmonary disease), ASA (American society of Anaesthesiology), SOFA (Sequential organ failure assessment), ICU (Intensive care unit).